ALK and non-small cell lung carcinoma: This kind of model has already been successfully developed for ALK-positive ALCL [149,150,151], ALK-positive NSCLC [152], Rhabdomyosarcoma [153], and Neuroblastoma [154], and are considered as the most reliable tumor model.